Indianapolis - Eli Lilly is selling its Greenfield Laboratories, creating an uncertain future for hundreds of employees.
One of the world's leading drug development services companies called Covance will pay $50 million for the Greenfield Laboratories and then sign a 10-year service agreement to take over the toxicology testing and other R&D support activities at the site.
Around 260 employees will get a job offer with Covance or can apply for limited roles within Lilly.
Employees who leave Lilly will get a severance package.
Another 225 workers based in Greenfield will move to Lilly sites in Indianapolis.
